再発性および転移性領域に重点を置いたがん治療薬の世界市場は、2024年の1,161億ドルと推定されました、2024年から2029年までの予測期間中に7.7%のCAGRで成長し、2029年末までに1,680億ドルに達すると予測されます。
目次
Chapter- 1: Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter- 2: Market Overview
Overview
Metastatic or Recurrent Cancer Treatment Types
Porter's Five Forces Analysis in the Oncology Market
Chapter- 3: Market Dynamics
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Chapter- 4: Regulatory Landscape
The U.S. Approval Process
European Union Approval Process
Japanese Approval Process
Chapter- 5: Emerging Trends and Pipeline Analysis
Emerging Technologies
New Developments
Biosimilar Approvals
Pipeline Analysis
Patent Analysis
Chapter- 6: Supply Chain Analysis
Overview
Cancer Drug Shortage
Chapter- 7: Market Segmentation Analysis
Segmentation Breakdown
Market Analysis, by Cancer Type
Geographic Breakdown
Market Analysis, by Region
Chapter- 8: Competitive Intelligence
Overview
Blockbuster Oncology Pharmaceutical Brands
Global Market Shares of Leading Companies
Chapter- 9: Sustainability in Cancers Therapeutics Market Emphasis on Recurrent and Metastatic Divisions: ESG Perspective
Role of ESG in the Pharma Industry
ESG Performance Analysis
ESG Risk Ratings
Conclusion
Chapter- 10: Appendix
Methodology
Emerging Start-ups/Market Disruptors
Sources
Abbreviations
Company Profiles
